FGF18 and osteoarthritis: By utilizing chondrocyte affinity peptide (CAP)-conjugated heteroexosomes (CAP/FGF18-hyexo) loaded with FGF18-targeting gene editing tools, a CRISPR/Cas9-based approach efficiently activates the FGF18 gene in osteoarthritis chondrocytes in vivo.